跳至主要内容
临床试验/DRKS00004635
DRKS00004635招募中不适用

SFB/TR22 - Allergic immune reaction in the lung - SFB A22: CLARA study

Dr. von Haunersches Kinderspital0 个研究点目标入组 200 人开始时间: 2014年4月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
4 Years 至 14 Years(—)
性别
All

入选标准

  • Age 4-14, recurrent pulmonary infections with airway obstruction / wheeze, more than 3 doctor´s diagnosed obstructive bronchitis. Intake of short-or long- acting beta 2-agonists, inhaled corticosteroides, leukotriene antagonists. Detailed clinical examination including lung-function.

排除标准

  • Exclusion criteria for asthmatics:
  • Any other pulmonary diseases (e.g. cystic fibrosis, bronchopulmonary dysplasia), any other chronic diseas, autoimmune diseases, immune deficiency, fever 14 day before inclusion, intake of antibiotics and probiotics 14 day before inclusion, intake of corticosteroides 14 days before inclusion, hypersensitization-therapy
  • Exclusion criteria for healthy controls:
  • Any pulmonary diseases (e.g. cystic fibrosis, bronchopulmonary dysplasia), any allergic diseases, any other chronic diseas, autoimmune diseases, immune deficiency, fever 14 day before inclusion, intake of antibiotics or probiotics 14 day before inclusion

研究者

发起方
Dr. von Haunersches Kinderspital

相似试验